Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight

The cell and gene therapy CDMO market is projected to grow from USD 8.3 billion in 2025 to USD 57.1 billion by 2034, driven by increasing clinical development of advanced therapies, rising outsourcing trends among biopharma companies, and technological advancements in manufacturing. North America leads the market with 40% share, while Asia-Pacific emerges as a significant growth hub. Key players are expanding manufacturing capabilities through strategic partnerships.

06/18/2026, 1:00 PM • GlobeNewswire

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

The global protein synthesis research market is experiencing accelerating growth driven by increased investment in cell and gene therapy research, rising chronic disease prevalence, and expanding healthcare budgets. North America leads with 42.8% market share, while Asia-Pacific infrastructure expansion presents significant growth opportunities. Key market drivers include strong late-stage therapy pipelines and government support through initiatives like the CHIPS and Science Act.

05/18/2026, 2:33 PM • GlobeNewswire

Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight

The plasmid DNA manufacturing market is projected to grow from USD 2.4 billion in 2025 to USD 10.8 billion by 2034, driven by rising demand for gene therapies, DNA vaccines, and CAR-T treatments. North America leads the market with 44.12% share, while Asia-Pacific emerges as a significant growth engine. Major companies are expanding GMP-compliant manufacturing capabilities to meet increasing demand from biopharmaceutical companies and CDMOs.

05/04/2026, 1:00 PM • GlobeNewswire

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Research Report 2026: Opportunities, Trends, Competitive Landscape, Strategies, Forecasts 2020-2035

The pharmaceutical Contract Development and Manufacturing Organization (CDMO) for formulations market is experiencing rapid growth with a projected CAGR of 10.6% through 2030. Growth drivers include increased outsourcing of peptide API manufacturing, expansion of GMP-grade production, and advancements in biologic formulation platforms. Strategic acquisitions and innovations in high-concentration protein formulations are reshaping the competitive landscape.

04/30/2026, 12:00 PM • GlobeNewswire

[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global cell culture media bags market is valued at USD 1.30 billion in 2025 and is projected to reach USD 2.28 billion by 2035, growing at a CAGR of 5.8%. Growth is driven by increased R&D investments in life sciences, adoption of single-use bioprocessing technologies, and automation trends in biopharmaceutical manufacturing. Single-use bags and EVA materials dominate the market segments, with North America leading in market share and Asia Pacific showing the highest growth rate.

04/29/2026, 12:30 AM • GlobeNewswire

Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight

The AAV vector manufacturing market is projected to grow from USD 874 million in 2025 to USD 5.2 billion by 2034, driven by expanding gene therapy research, increasing regulatory approvals, and rising investments in biomanufacturing infrastructure. North America leads the market with 43% share, while Asia-Pacific emerges as a key growth engine. Key drivers include growing prevalence of genetic disorders, technological advancements in manufacturing, and expansion of outsourcing to CDMOs.

04/28/2026, 1:00 PM • GlobeNewswire

Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

The drug development services market is projected to grow from $28.09 billion in 2025 to $50.26 billion by 2030 at a CAGR of 12.4%, driven by increased R&D investments, AI adoption, personalized medicine, and emerging market expansion. Key growth areas include preclinical research, regulatory optimization, and cloud-based data management, with precision medicine and genomics advancements playing pivotal roles.

04/14/2026, 10:59 AM • GlobeNewswire

Wood Preservatives Market Size to Hit USD 2.73 Billion by 2035, Driven by Rising Construction Activity and Demand for Durable Wood | Research by SNS Insider

The global wood preservatives market is projected to grow from USD 1.68 billion in 2025 to USD 2.73 billion by 2035, with a CAGR of 5.04%. Growth is driven by increased construction activity, demand for durable wood products, and stricter regulations. Water-based preservatives dominate with 70.87% market share, while the residential application segment leads with 39.68%. Asia Pacific is the fastest-growing region at 7.66% CAGR.

04/06/2026, 2:50 AM • GlobeNewswire

Synthetic Glycerol Market Size to Hit USD 1.98 Billion by 2035 | Research by SNS Insider

The U.S. synthetic glycerol market is expected to grow from USD 0.34 billion in 2025 to USD 0.68 billion by 2035 at a CAGR of 7.10%, driven by stringent regulatory standards, sustainable formulations, and expanding pharmaceutical and personal care manufacturing. The global market is valued at USD 1.12 billion in 2025 and projected to reach USD 1.98 billion by 2035 at a CAGR of 5.91%, with Asia-Pacific dominating at 37% market share.

03/03/2026, 12:10 AM • GlobeNewswire

Global Biopharmaceutical CMO Market Projected to Reach USD 76.20 Billion by 2035, Fueled by Rising Biologics Demand and Expanding Outsourcing Strategies – SNS Insider

The global biopharmaceutical contract manufacturing organization (CMO) market is estimated at USD 21.16 billion in 2025 and is projected to grow to USD 76.20 billion by 2035, with a CAGR of 13.67%. Growth is driven by rising biologics demand, capacity constraints among innovator firms, and increased outsourcing strategies by pharmaceutical companies. North America holds the largest market share at 43.67%, while Asia Pacific shows the fastest growth at 15.23% CAGR.

02/24/2026, 4:00 AM • GlobeNewswire

Cell Therapy Processing Market to Grow 21.4% Annually Through 2030

The global cell therapy processing market is projected to grow from $2.7 billion in 2025 to $7.1 billion by 2030, at a CAGR of 21.4%. Growth is driven by rising demand for advanced cell therapies including CAR-T, increasing R&D investments, expanding clinical trials, and an aging population with chronic diseases. Key challenges include complex manufacturing, regulatory hurdles, and workforce shortages. North America leads the market with the highest share.

02/05/2026, 1:47 PM • GlobeNewswire

[Latest] Global Adeno Associated Virus Vector Manufacturing Market Size/Share Worth USD 9.87 Billion by 2035 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)

The global Adeno Associated Virus (AAV) vector manufacturing market is projected to grow from USD 2.84 billion in 2025 to USD 9.87 billion by 2035, at a CAGR of 13.4%. Growth is driven by increased clinical trials, regulatory approvals of AAV-based gene therapies, technological innovations in manufacturing processes, and rising demand from pharmaceutical companies and CDMOs. North America leads the market while Asia Pacific shows the fastest growth rate.

02/03/2026, 1:00 PM • GlobeNewswire

Middle East Exosomes Market Research Report 2025-2033: Diagnostic and Therapeutic Adoption, R&D Investment, and Liquid Biopsy Demand Drive Growth

The Middle East exosomes market is projected to grow from USD 3.07 million in 2024 to USD 20.03 million by 2033, at a CAGR of 23.38%. Growth is driven by increasing adoption of exosome-based diagnostics and therapeutics, rising biomedical R&D investment, and growing demand for liquid biopsy technologies. Key challenges include stringent regulatory requirements and high manufacturing costs.

01/21/2026, 4:42 AM • GlobeNewswire

Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica

The global single-use bioprocessing market is expected to grow from USD 30.12 billion in 2025 to USD 122.92 billion by 2035 at a CAGR of 15.1%. Driven by technological breakthroughs in bioreactor scalability (up to 6,000L), 40-50% CAPEX reductions, and FDA approvals of 16 single-use-manufactured biologics in 2024, the market is becoming the standard for commercial biomanufacturing. Major players are expanding capacity significantly, with CDMOs like WuXi Biologics managing substantial backlogs.

01/20/2026, 12:38 PM • GlobeNewswire

Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider

The global bioconjugation market is projected to grow from USD 5.46 billion in 2025 to USD 14.51 billion by 2033, at a CAGR of 13.05%. Growth is driven by increasing demand for targeted therapeutics, antibody-drug conjugates, advances in conjugation chemistries, and biopharmaceutical R&D investments. North America leads with 45.50% market share, while Asia Pacific is expected to grow fastest at 14.98% CAGR. High costs and technical complexity remain challenges.

01/19/2026, 11:00 AM • GlobeNewswire